BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6261034)

  • 1. [Peripheral blood changes infections and supportive care under intensive chemotherapy for solid tumors CT2 and T6 protocol) (author's transl)].
    Göbel U; Jürgens H; Ebell W; Wahn V
    Klin Padiatr; 1980 Nov; 192(6):517-22. PubMed ID: 6261034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of adjuvant chemotherapy in malignant tumors in children].
    Gaedicke G
    Aktuelle Probl Chir Orthop; 1982; 22():18-21. PubMed ID: 6121508
    [No Abstract]   [Full Text] [Related]  

  • 3. [What is certain in the chemotherapy of solid tumors?].
    Seeber S; Schmidt CG
    Internist (Berl); 1977 Dec; 18(12):631-41. PubMed ID: 202568
    [No Abstract]   [Full Text] [Related]  

  • 4. [New perspectives for an adjuvant chemotherapy in solid tumors].
    Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2342-8. PubMed ID: 171129
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric malignant solid tumors.
    Pratt CB
    Cancer Chemother Biol Response Modif; 1991; 12():635-49. PubMed ID: 1657091
    [No Abstract]   [Full Text] [Related]  

  • 6. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytostatic adjuvant therapy from the viewpoint of the pediatrician].
    Lampert F
    Haematol Blood Transfus; 1978; 22():137-44. PubMed ID: 220152
    [No Abstract]   [Full Text] [Related]  

  • 8. [The chemotherapy of solid tumors in childhood].
    Widmer U; Morbidelli R; Naddeo-Bolgiani MP
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1967; 60(11):624-40. PubMed ID: 4304184
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current problems of solid tumors in childhood].
    Plüss HJ; Sartorius J; Wagner HP; Wyss M
    Schweiz Med Wochenschr; 1974 May; 104(18):634-41. PubMed ID: 4363542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Solid tumors in childhood. With special reference to cytostatic treatment].
    Dombernowsky P; Nissen NI; Hansen HH; Pedersen-Bjergaard J
    Ugeskr Laeger; 1978 Feb; 140(7):335-40. PubMed ID: 204092
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to single-dose dactinomycin in combination chemotherapy for solid tumors.
    Blatt J; Trigg ME; Pizzo PA; Glaubiger D
    Cancer Treat Rep; 1981; 65(1-2):145-7. PubMed ID: 7226164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumptive coagulopathy. A complication of therapy of solid tumors in childhood.
    Sills RH; Stockman JA; Miller ML; Stuart MJ
    Am J Dis Child; 1978 Sep; 132(9):870-2. PubMed ID: 685903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Supportive care for patients receiving CESS 81 chemotherapy for Ewing's sarcoma (author's transl)].
    Göbel U
    Klin Padiatr; 1981 May; 193(3):245-50. PubMed ID: 6167758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in the treatment of pediatric malignancies.
    Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)].
    Krizan Z; Makai F; Krizan I; Blasková L; Látal J; Majeský B
    Acta Chir Orthop Traumatol Cech; 1979 Feb; 46(1):26-8. PubMed ID: 88152
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
    Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
    Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ewing's sarcoma: therapeutic experience (author's transl)].
    Ribeiro-Ayeh J; Walther A; Horrig C
    Monatsschr Kinderheilkd; 1982 Jan; 130(1):30-5. PubMed ID: 6174858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.